U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032
Overview
The U.S. Duchenne Muscular Dystrophy Treatment Market 2030 is expected to reach a 5.64 USD Billion by 2032 and is projected to grow at a CAGR of 24.71% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.54
Forecast, 2032 (USD Billion)
5.64
CAGR, 2024 - 2032
24.71%
Report Coverage
U.S.
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 2018-2032 USD Billion
U.S. Duchenne Muscular Dystrophy Treatment Market 2030, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.54 USD Billion
- Projected Market Size (2032): 5.64 USD Billion
- CAGR (2025-2032): 24.71%
Key Findings of U.S. Duchenne Muscular Dystrophy Treatment Market 2030
- The U.S. Duchenne Muscular Dystrophy Treatment Market 2030 was valued at 1.54 USD Billion in 2024.
- The U.S. Duchenne Muscular Dystrophy Treatment Market 2030 is likely to grow at a CAGR of 24.71% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Parenteral in Route of Administration Segment accounted for the largest share of the market with a revenue of 1.05 USD Billion
- The fastest growing segment Steroid Therapy in Treatment Segment grew Fastest with a CAGR of 26.22% during the forecast period from 2024 to 2032.
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 Scope
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 Segmentation & Scope
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Homecare
- Specialty Clinics
- Hospitals
Treatment
- Others
- Steroid Therapy
- Molecular-Based Therapies
Therapy
- Dystrophin-Targeted Therapies
- Mutation Suppression
- Exon Skipping Approach
Route of Administration
- Others
- Oral
- Parenteral
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.54 USD Billion |
| Market Value in 2032 | 5.64 USD Billion |
| CAGR (2025-2032) | 24.71% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Treatment,Therapy,Route of Administration |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 1.54 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,537.84 USD Million in 2024.
Segments and Scope
-
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a revenue of 892.07 USD Billion in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a Growth rate of 25.57 % in forecast period 2025-2032.
-
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032, By End User
- Hospitals is the largest segment in U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a revenue of 685.45 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a Growth rate of 25.78 % in forecast period 2025-2032.
-
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032, By Treatment
- Molecular-Based Therapies is the largest segment in U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a revenue of 787.58 USD Billion in the year 2024.
- Steroid Therapy is the Fastest growing segment in U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a Growth rate of 24.47 % in forecast period 2025-2032.
-
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032, By Therapy
- Exon Skipping Approach is the largest segment in U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a revenue of 695.73 USD Billion in the year 2024.
- Exon Skipping Approach is the Fastest growing segment in U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a Growth rate of 25.58 % in forecast period 2025-2032.
-
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032, By Route of Administration
- Parenteral is the largest segment in U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a revenue of 1.05 USD Billion in the year 2024.
- Parenteral is the Fastest growing segment in U.S. Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a Growth rate of 25.62 % in forecast period 2025-2032.
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 Company Share Analysis
| Company Name |
|
||
| Pfizer Inc. | |||
| F. Hoffmann-La Roche Ltd. | |||
| PTC Therapeutics. | |||
| Sarepta Therapeutics, Inc. | |||
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 Geographical Sales Distribution, 2018-2032 USD Billion
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Duchenne Muscular Dystrophy Treatment Market 2030 is segmented based on Segmentation Distribution Channel,End User,Treatment,Therapy,Route of Administration .
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 was valued at USD 1.54(Revenue in USD Billion) in 2021.
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 is projected to grow at a CAGR of 24.71% during the forecast period of 2024 to 2032.
The Parenteral segment is expected to dominate the U.S. Duchenne Muscular Dystrophy Treatment Market 2030, holding a largest market share of 1.05 USD Billion in 2024
Coming Soon....
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 Scope
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 Segmentation & Scope
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Homecare
- Specialty Clinics
- Hospitals
Treatment
- Others
- Steroid Therapy
- Molecular-Based Therapies
Therapy
- Dystrophin-Targeted Therapies
- Mutation Suppression
- Exon Skipping Approach
Route of Administration
- Others
- Oral
- Parenteral
Frequently Asked Questions
The U.S. Duchenne Muscular Dystrophy Treatment Market 2030 is segmented based on Segmentation Distribution Channel,End User,Treatment,Therapy,Route of Administration .
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 was valued at USD 1.54(Revenue in USD Billion) in 2021.
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 is projected to grow at a CAGR of 24.71% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Duchenne Muscular Dystrophy Treatment Market 2030 for final year is USD 5.64 (USD Billion).
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 Company Profiling
Frequently Asked Questions
The U.S. Duchenne Muscular Dystrophy Treatment Market 2030 is segmented based on Segmentation Distribution Channel,End User,Treatment,Therapy,Route of Administration .
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 was valued at USD 1.54(Revenue in USD Billion) in 2021.
U.S. Duchenne Muscular Dystrophy Treatment Market 2030 is projected to grow at a CAGR of 24.71% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Duchenne Muscular Dystrophy Treatment Market 2030 for final year is USD 5.64 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.